Zenshine Biotech

Zenshine Biotech

至善唯新

Zenshine Biotech

Biotech/Healthcare

Founded in 2018, Zhishan Weixin is a leading Chinese gene therapy company focused on the development and disruptive manufacturing of rAAV-based gene therapies. Its pipeline covers hematologic disorders, rare diseases, and other therapeutic areas.

Latest round: Series B Extension (2025)

Source: ChinaBulls — chinabulls.com

Last updated 2025-12-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.